Labcorp Holdings INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Labcorp Holdings Inc. announced its 2026 Annual Meeting of Shareholders, scheduled for May 21, 2026, and provided a comprehensive overview of its 2025 performance and strategic priorities.
NYSE
Labcorp Holdings Inc. announces its 2025 Annual Meeting of Shareholders, detailing proposals for director elections, executive compensation, incentive plans, and auditor ratification.
NYSE
Labcorp announces its 2025 Annual Shareholder Meeting and reflects on a year of strong financial performance and strategic advancements.
NYSE
DEFA14A: Labcorp to Hold Annual Shareholder Meeting, Voting on Director Elections and Executive Compensation
Laboratory Corporation of America Holdings (Labcorp) will hold its annual shareholder meeting on May 14, 2024, to vote on key proposals including the election of directors, executive compensation, and ratification of the company's auditor.
NYSE
Labcorp's 2024 proxy statement outlines the company's transformational year in 2023, marked by the successful spin-off of Fortrea and continued focus on growth opportunities.